Genome sequencing of Enterobacterales isolates exhibiting reduced susceptibility to meropenem and carrying carbapenemase genes in Japan in 2023
This project focuses on carbapenemase-carrying Enterobacterales isolates with reduced susceptibility to meropenem collected through a nationwide surveillance in Japan since 2023 (JARBS-GNR/VRE 2.0), and aims to investigate the effectiveness of novel antimicrobials against these isolates.